M
Mohinder P. Mahajan
Researcher at Guru Nanak Dev University
Publications - 116
Citations - 1557
Mohinder P. Mahajan is an academic researcher from Guru Nanak Dev University. The author has contributed to research in topics: Cycloaddition & Pyrimidinones. The author has an hindex of 20, co-authored 116 publications receiving 1464 citations. Previous affiliations of Mohinder P. Mahajan include North Eastern Hill University.
Papers
More filters
Journal ArticleDOI
1,2,3-Triazole tethered β-lactam-chalcone bifunctional hybrids: synthesis and anticancer evaluation.
Pardeep Singh,Raghu Raj,Vipan Kumar,Mohinder P. Mahajan,Preet Ms Bedi,Tandeep Kaur,Ajit Kumar Saxena +6 more
TL;DR: The synthesis of novel 1,2,3-triazole tethered β-lactam-chalcone bifunctional hybrids via click chemistry approach utilizing azide-alkyne cycloaddition reactions and their evaluation as anticancer agents against four human cancer cell lines are described.
Journal ArticleDOI
Recent advances in synthetic applications of azadienes
Journal ArticleDOI
Synthesis and biological activity of novel antibacterial quinazolines.
TL;DR: Novel quinazolines, having interesting antibacterial activity have been prepared, characterized and tested against a panel of susceptible and resistant Gram positive and Gram negative organisms.
Journal ArticleDOI
A catalyst- and solvent-free selective approach to biologically important quinazolines and benzo[g]quinazoline
TL;DR: In this paper, a solvent-free and catalyst-free approach for the selective synthesis of quinazolines and benzo[g] quinzolines has been developed using conventional microwave oven with excellent yields and reproducibilty.
Journal ArticleDOI
Synthesis, docking and in vitro antimalarial evaluation of bifunctional hybrids derived from β-lactams and 7-chloroquinoline using click chemistry
Pardeep Singh,Parvesh Singh,Malkeet Kumar,Jiri Gut,Philip J. Rosenthal,Kewal Kumar,Vipan Kumar,Mohinder P. Mahajan,Krishna Bisetty +8 more
TL;DR: 1,2,3-Triazole tethered β-lactam and 7-chloroquinoline bifunctional hybrids were synthesized and evaluated as potential antimalarial agents and observed activity profiles were substantiated by docking studies via inhibition of P. falciparum dihydrofolate reductase (PfDHFR), a potential target for the development of new anti-malarials.